Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MPTP: clinical implications.

G Stern

    Journal of Neural Transmission. Supplementum
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    This review explores the historical concept of basal ganglia selective vulnerability. It considers the implications of MPTP and the protective potential of monoamine oxidase (MAO) inhibition for Parkinson's disease treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Association, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, Vancouver, BC, Sept. 17-21, 2013.

    Canadian journal of surgery. Journal canadien de chirurgie·2025
    Same author

    A fibered laser system for the MIGA large scale atom interferometer.

    Scientific reports·2020
    Same author

    Watt-level narrow-linewidth fibered laser source at 852 nm for FIB application.

    Optics letters·2018
    Same author

    [Wound management with enzyme alginogels : Expert consensus].

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2016
    Same author

    Hallucinations and parkinsonian motor fluctuations.

    Behavioural neurology·2014
    Same author

    Dual-wavelength laser source for onboard atom interferometry.

    Optics letters·2011
    Same journal

    Intake of tomato-enriched diet protects from 6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons.

    Journal of neural transmission. Supplementum·2010
    Same journal

    A diet for dopaminergic neurons?

    Journal of neural transmission. Supplementum·2010
    Same journal

    Immunization as treatment for Parkinson's disease.

    Journal of neural transmission. Supplementum·2010
    Same journal

    Gene therapy for Parkinson's disease.

    Journal of neural transmission. Supplementum·2010
    Same journal

    Stem cells and cell replacement therapy for Parkinson's disease.

    Journal of neural transmission. Supplementum·2010
    Same journal

    Neurogenesis in substantia nigra of parkinsonian brains?

    Journal of neural transmission. Supplementum·2010
    See all related articles

    Area of Science:

    • Neuroscience
    • Neuropharmacology
    • Neuropathology

    Background:

    • The basal ganglia exhibit selective vulnerability in neurodegenerative conditions.
    • The neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) has been instrumental in understanding Parkinson's disease pathogenesis.
    • Monoamine oxidase (MAO) enzymes play a role in dopamine metabolism and are implicated in neuroprotection.

    Purpose of the Study:

    • To historically review the concept of selective basal ganglia vulnerability.
    • To discuss the implications of MPTP exposure on basal ganglia.
    • To examine the potential of selective MAO inhibition as a therapeutic strategy for Parkinson's disease.

    Main Methods:

    • Historical literature review.
    • Analysis of studies on MPTP neurotoxicity.

    Related Experiment Videos

  • Examination of research on MAO inhibitors and their effects.

    • Main Results:

    • MPTP selectively damages dopaminergic neurons in the substantia nigra, a key component of the basal ganglia.
    • Selective MAO-B inhibition has shown neuroprotective effects in preclinical models.
    • Understanding selective vulnerability informs targeted therapeutic approaches.

    Conclusions:

    • Selective vulnerability of the basal ganglia is a crucial concept in Parkinson's disease research.
    • MPTP serves as a model for studying basal ganglia degeneration.
    • Targeted MAO inhibition represents a promising avenue for Parkinson's disease treatment, leveraging the principle of selective vulnerability.